Company intelligence / Profile preview

Sorintellis

Montreal, Quebec, Canadasorintellisgroup.com ↗

Ownership: Private
Development stage: Other

Overview

Sorintellis has developed proprietary AI-driven platforms—DDRNAi and PPMAi—to provide actionable insights and multidimensional risk estimation in pharmaceutical portfolio management. Their solutions are designed to optimize drug development by supporting Go/No Go decisions, reducing avoidable risks in clinical trials, and increasing both commercial and therapeutic value of pipelines.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Sorintellis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorintellis.

Explore the full profile